HPG
Harvest Portfolios Group Portfolio holdings
AUM
$4.3B
This Quarter Return
+11.17%
1 Year Return
+16.34%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.36B
AUM Growth
+$2.36B
(+11%)
Cap. Flow
+$31.9M
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
25.91%
Holding
225
New
7
Increased
64
Reduced
145
Closed
7
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$72.6M |
| 2 |
CrowdStrike
CRWD
|
$21.8M |
| 3 |
Synopsys
SNPS
|
$19.5M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
$18.6M |
| 5 |
Cisco
CSCO
|
$17.8M |
Top Sells
| 1 |
Citigroup
C
|
$20.8M |
| 2 |
Keysight
KEYS
|
$16.2M |
| 3 |
Fortinet
FTNT
|
$15.4M |
| 4 |
Amgen
AMGN
|
$9.94M |
| 5 |
UnitedHealth
UNH
|
$8.35M |
Sector Composition
| 1 | Healthcare | 47.28% |
| 2 | Technology | 19.58% |
| 3 | Financials | 7.02% |
| 4 | Consumer Discretionary | 5.24% |
| 5 | Communication Services | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares 20+ Year Treasury Bond ETF
TLT
$47.8B
| $78M | 3.31% | 788,623 +734,038 | +1,345% | +$72.6M |
|
2
Johnson & Johnson
JNJ
$427B
| $70.1M | 2.98% | 447,539 +13,348 | +3% | +$2.09M |
|
|
3
UnitedHealth
UNH
$281B
| $66.7M | 2.83% | 126,722 -15,865 | -11% | -$8.35M |
|
4
Thermo Fisher Scientific
TMO
$186B
| $57.2M | 2.43% | 107,797 +10,098 | +10% | +$5.36M |
|
5
Agilent Technologies
A
$35.7B
| $57M | 2.42% | 409,860 -17,078 | -4% | -$2.37M |
|
6
Abbott
ABT
$231B
| $56.9M | 2.41% | 516,993 +10,952 | +2% | +$1.21M |
|
7
Danaher
DHR
$147B
| $56.8M | 2.41% | 245,730 +40,849 | +20% | +$9.45M |
|
8
Boston Scientific
BSX
$156B
| $56.4M | 2.39% | 976,110 -38,639 | -4% | -$2.23M |
|
9
Medtronic
MDT
$119B
| $56.2M | 2.38% | 681,978 +53,322 | +8% | +$4.39M |
|
10
Merck
MRK
$210B
| $55.6M | 2.36% | 509,926 -4,225 | -0.8% | -$461K |
|
11
AbbVie
ABBV
$372B
| $54.6M | 2.31% | 352,099 -14,149 | -4% | -$2.19M |
|
12
Eli Lilly
LLY
$657B
| $54.4M | 2.31% | 93,356 -2,600 | -3% | -$1.52M |
|
13
Regeneron Pharmaceuticals
REGN
$61.5B
| $53.6M | 2.27% | 61,001 -3,601 | -6% | -$3.16M |
|
14
Zoetis
ZTS
$69.3B
| $53.4M | 2.26% | 270,565 -23,316 | -8% | -$4.6M |
|
|
15
Amgen
AMGN
$155B
| $53.3M | 2.26% | 185,045 -34,511 | -16% | -$9.94M |
|
16
Novartis
NVS
$245B
| $52.6M | 2.23% | 521,332 +3,715 | +0.7% | +$375K |
|
17
AstraZeneca
AZN
$248B
| $52.2M | 2.21% | 774,746 -19,287 | -2% | -$1.3M |
|
18
Intuitive Surgical
ISRG
$170B
| $51.6M | 2.19% | 152,962 -22,302 | -13% | -$7.52M |
|
19
Bristol-Myers Squibb
BMY
$96B
| $51.6M | 2.19% | 1,005,155 +95,718 | +11% | +$4.91M |
|
20
Stryker
SYK
$150B
| $50.7M | 2.15% | 169,169 -17,617 | -9% | -$5.28M |
|
21
Elevance Health
ELV
$71.8B
| $50.2M | 2.13% | 106,483 -8,234 | -7% | -$3.88M |
|
22
Texas Instruments
TXN
$184B
| $40.1M | 1.7% | 235,275 +19,386 | +9% | +$3.3M |
|
23
Accenture
ACN
$162B
| $38M | 1.61% | 108,409 -14,182 | -12% | -$4.98M |
|
24
Alphabet (Google) Class A
GOOGL
$2.57T
| $38M | 1.61% | 272,232 -9,847 | -3% | -$1.38M |
|
25
Microsoft
MSFT
$3.77T
| $35.7M | 1.51% | 94,960 -21,399 | -18% | -$8.05M |
|